APOA5 and coronary artery disorder: Among T2D Indian participants, the –1131T/C variant of APOA5 and the Q192R variant of PON1 increased CHD risk by 1.5 times separately, with both effects having a similar strength of association (ORAPOA5: 1.50, p = 0.034; ORPON1: 1.49, p = 0.023).